 |
| Market Cap | 1.36M | EPS (ttm) | -0.83 |
| P/E | - | EPS this Y | - |
| Forward P/E | - | EPS next Y | - |
| PEG | - | EPS past 5Y | -25.09% |
| P/S | 0.01 | EPS next 5Y | - |
| P/B | - | EPS Q/Q | - |
| Dividend | - | Sales Q/Q | - |
| Insider Own | 27.10% | Inst Own | 3.84% |
| Insider Trans | 0.00% | Inst Trans | - |
| Short Float | 3.38% | Earnings | - |
| Analyst Recom | 1.00 | Target Price | 2400.00 |
| Avg Volume | 48.11K | 52W Range | 3.20 - 304.00 |
|
|
|
|
Tritium DCFC Ltd. designs and manufactures proprietary hardware and software to develop direct current chargers for electric vehicles. It operates through the following segments: Hardware, Software, and Service and Maintenance. The company was founded by David Finn, Paul Serina and James Kennedy on May 7, 2021 and is headquartered in Murarrie, Australia. |
|
 |
 |
| Market Cap | 2.16M | EPS (ttm) | -19.05 |
| P/E | - | EPS this Y | 115.79% |
| Forward P/E | 0.13 | EPS next Y | 466.67% |
| PEG | - | EPS past 5Y | 73.50% |
| P/S | 0.09 | EPS next 5Y | - |
| P/B | 0.03 | EPS Q/Q | 94.97% |
| Dividend | - | Sales Q/Q | 94.94% |
| Insider Own | 4.14% | Inst Own | - |
| Insider Trans | 292.78% | Inst Trans | -13.41% |
| Short Float | 0.74% | Earnings | Mar 28/b |
| Analyst Recom | 1.00 | Target Price | 300.00 |
| Avg Volume | 358.00K | 52W Range | 3.10 - 140.00 |
|
|
|
|
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product includes treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in New York, NY. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Slilaty Steve N. | Chief Executive Officer | Mar 04 '24 | Buy | 0.10 | 100,000 | 10,000 | 130,000 | Mar 05 04:05 PM | | Slilaty Steve N. | Chief Executive Officer | Feb 08 '24 | Buy | 0.10 | 20,000 | 2,000 | 30,000 | Feb 12 04:05 PM |
|
|
|
 |
| Market Cap | 13.74M | EPS (ttm) | -9.68 |
| P/E | - | EPS this Y | - |
| Forward P/E | - | EPS next Y | - |
| PEG | - | EPS past 5Y | - |
| P/S | 2.20 | EPS next 5Y | - |
| P/B | 0.82 | EPS Q/Q | 46.83% |
| Dividend | - | Sales Q/Q | -71.60% |
| Insider Own | 11.31% | Inst Own | 0.65% |
| Insider Trans | 0.00% | Inst Trans | - |
| Short Float | 5.77% | Earnings | - |
| Analyst Recom | - | Target Price | - |
| Avg Volume | 521.38K | 52W Range | 1.25 - 9.71 |
|
|
|
|
Bit Origin Ltd. operates as an emerging growth company which engages in crypto mining business. The firm also actively deploys blockchain technologies, alongside diversified expansion strategies. It has operations in the United States, Canada, and China. The company was founded on January 23, 2018 and is headquartered in New York, NY. |
|
| |
 |
| Market Cap | 7.81M | EPS (ttm) | -0.03 |
| P/E | - | EPS this Y | - |
| Forward P/E | - | EPS next Y | - |
| PEG | - | EPS past 5Y | - |
| P/S | 1.27 | EPS next 5Y | - |
| P/B | 17.63 | EPS Q/Q | 17.76% |
| Dividend | - | Sales Q/Q | -27.16% |
| Insider Own | 38.41% | Inst Own | 0.08% |
| Insider Trans | 0.00% | Inst Trans | - |
| Short Float | 1.67% | Earnings | - |
| Analyst Recom | - | Target Price | - |
| Avg Volume | 14.09K | 52W Range | 3.10 - 19.70 |
|
|
|
|
Golden Sun Health Technology Group Ltd. is a holding company, which engages in the provision of tutorial services. It focuses on the development of each of students' strengths and potential, and the promotion of life-long skills and interests in learning. The company was founded in 1997 and is headquartered in Shanghai, China. |
|
|
 |
| Market Cap | 15.09M | EPS (ttm) | -1.45 |
| P/E | - | EPS this Y | - |
| Forward P/E | - | EPS next Y | - |
| PEG | - | EPS past 5Y | -483.40% |
| P/S | 0.52 | EPS next 5Y | - |
| P/B | 0.76 | EPS Q/Q | -320.24% |
| Dividend | - | Sales Q/Q | - |
| Insider Own | 69.53% | Inst Own | 0.18% |
| Insider Trans | 0.00% | Inst Trans | -98.39% |
| Short Float | 41.63% | Earnings | - |
| Analyst Recom | - | Target Price | - |
| Avg Volume | 9.46M | 52W Range | 1.50 - 113.00 |
|
|
|
|
MicroCloud Hologram, Inc. engages in research, development, and application of holographic technology. It operates through the Holographic Solutions and Holographic Technology Service segments. The company was founded in 2020 and is headquartered in New York, NY. |
|
| |
 |
| Market Cap | 2.07M | EPS (ttm) | 142.64 |
| P/E | 0.01 | EPS this Y | - |
| Forward P/E | - | EPS next Y | - |
| PEG | - | EPS past 5Y | - |
| P/S | 0.07 | EPS next 5Y | - |
| P/B | 0.00 | EPS Q/Q | 658.66% |
| Dividend | - | Sales Q/Q | 910.20% |
| Insider Own | 0.53% | Inst Own | 7.67% |
| Insider Trans | 0.00% | Inst Trans | - |
| Short Float | 2.04% | Earnings | Mar 26/b |
| Analyst Recom | - | Target Price | - |
| Avg Volume | 1.02M | 52W Range | 1.21 - 2000.00 |
|
|
|
|
C3is, Inc. is a holding company that engages in the provision of seaborne transportation services to dry bulk charterers through its subsidiaries. It offers services to dry bulk charterers such as national and private industrial users, commodity producers, and commodity traders. The company was founded on July 25, 2022 and is headquartered in Athens, Greece. |
|
|
 |
| Market Cap | 40.57M | EPS (ttm) | -24.76 |
| P/E | - | EPS this Y | - |
| Forward P/E | - | EPS next Y | - |
| PEG | - | EPS past 5Y | - |
| P/S | 4.15 | EPS next 5Y | - |
| P/B | 9.31 | EPS Q/Q | 81.63% |
| Dividend | - | Sales Q/Q | 28.88% |
| Insider Own | 0.88% | Inst Own | 3.02% |
| Insider Trans | 0.00% | Inst Trans | 59.87% |
| Short Float | 1.91% | Earnings | - |
| Analyst Recom | - | Target Price | - |
| Avg Volume | 10.44M | 52W Range | 0.14 - 14.00 |
|
|
|
|
Connexa Sports Technologies, Inc. engages in the design and development of portable ball launchers, and other practice equipment solutions for all ball sports. The company was founded by Joe Kalfa in 2017 and is headquartered in Windsor Mill, DE. |
|
| |
 |
| Market Cap | 13.69M | EPS (ttm) | - |
| P/E | - | EPS this Y | - |
| Forward P/E | - | EPS next Y | - |
| PEG | - | EPS past 5Y | 5.28% |
| P/S | - | EPS next 5Y | - |
| P/B | 0.91 | EPS Q/Q | 73.16% |
| Dividend | - | Sales Q/Q | -48.79% |
| Insider Own | 91.93% | Inst Own | 0.11% |
| Insider Trans | -0.04% | Inst Trans | 5.90% |
| Short Float | 1.80% | Earnings | Nov 27/b |
| Analyst Recom | - | Target Price | - |
| Avg Volume | 50.60K | 52W Range | 0.58 - 4.13 |
|
|
|
|
BIMI International Medical, Inc. engages in the provision of healthcare products and services. It operates through the following segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. The Wholesale Pharmaceuticals segment includes supplying prescription and OTC medicines, TCM, healthcare supplies and sundry items to clinics, third party pharmacies, hospitals, and other drug vendors. The Wholesale Medical Devices segment distributes medical devices, including medical consumables to drug stores, private clinics, pharmaceutical dealers and hospitals. The Medical Services segment includes the hospitals acquired in 2021.The Retail Pharmacy segment sells prescription and OTC medicines, traditional Chinese medicines ("TCM"), healthcare supplies, and sundry items to retail customers through its directly-owned pharmacies and authorized retail stores. The company was founded on October 31, 2000 and is headquartered in New York, NY. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Tiewei Song | CEO | Feb 28 '24 | Sale | 4.08 | 4,000 | 16,300 | 337,117 | Mar 04 04:01 PM | | Tiewei Song | CEO | Feb 26 '24 | Sale | 4.01 | 724 | 2,903 | 341,117 | Mar 04 04:03 PM |
|
|
|
 |
| Market Cap | 48.51B | EPS (ttm) | 12.79 |
| P/E | 64.77 | EPS this Y | 85.89% |
| Forward P/E | 26.79 | EPS next Y | 40.91% |
| PEG | 1.34 | EPS past 5Y | 66.82% |
| P/S | 5.24 | EPS next 5Y | 48.20% |
| P/B | 15.06 | EPS Q/Q | 62.41% |
| Dividend | - | Sales Q/Q | 103.25% |
| Insider Own | 14.27% | Inst Own | 70.60% |
| Insider Trans | -2.37% | Inst Trans | 2.20% |
| Short Float | 6.18% | Earnings | Jan 29/a |
| Analyst Recom | 1.89 | Target Price | 902.29 |
| Avg Volume | 11.00M | 52W Range | 93.19 - 1229.00 |
|
|
|
Today 09:05AM
|
Supermicro to Announce Third Quarter Fiscal 2024 Earnings on April 30, 2024
(Business Wire) -10.76% |
|
04:25AM
|
Could Super Micro Computer Become the Next Dell Technologies?
(Motley Fool) |
|
03:34AM
|
History Says the Nasdaq Will Continue to Soar in 2024: My Top 5 Artificial Intelligence (AI) Growth Stocks to Buy Before the Surge Continues
(Motley Fool) |
|
Apr-17-24 05:45PM
|
Super Micro Computer (SMCI) Suffers a Larger Drop Than the General Market: Key Insights
(Zacks) |
|
04:39PM
|
Super Micro Computer Stock Seesaws, But Finds Support At Key Level
(Investor's Business Daily) |
|
10:07AM
|
Intel, Palantir, Super Micro, WiSA, and Other Tech Stocks in Focus Today
(Barrons.com) |
|
08:13AM
|
Intel, Super Micro Computer, WiSA, Applied Materials, and Other Tech Stocks in Focus Today.
(Barrons.com) |
|
05:48AM
|
2 Superb Artificial Intelligence (AI) Growth Stocks to Buy Before They Soar 63% and 70%, According to Select Wall Street Analysts
(Motley Fool) |
|
05:15AM
|
The Tech Stocks Making Waves Today
(Barrons.com) |
|
04:10AM
|
Could Super Micro Stock Help You Become a Millionaire?
(Motley Fool) |
|
Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| FAIRFAX DANIEL W | Director | Apr 01 '24 | Sale | 1010.00 | 300 | 303,000 | 19,487 | Apr 03 04:09 PM | | FAIRFAX DANIEL W | Director | Mar 01 '24 | Sale | 881.88 | 300 | 264,564 | 19,787 | Mar 05 04:21 PM | | TUAN SHERMAN | Director | Feb 29 '24 | Sale | 873.98 | 5,000 | 4,369,884 | 22,113 | Mar 04 05:34 PM | | KAO GEORGE | SVP, OPERATIONS | Feb 15 '24 | Sale | 993.00 | 1,884 | 1,870,812 | 8,496 | Feb 20 04:51 PM | | CLEGG DON W | SVP, Worldwide Sales | Feb 14 '24 | Option Exercise | 23.75 | 28,000 | 665,060 | 30,837 | Feb 16 05:07 PM |
|
|
|
 |
| Market Cap | 3.73M | EPS (ttm) | -8.66 |
| P/E | - | EPS this Y | - |
| Forward P/E | - | EPS next Y | - |
| PEG | - | EPS past 5Y | 17.42% |
| P/S | 1.23 | EPS next 5Y | - |
| P/B | - | EPS Q/Q | 82.40% |
| Dividend | - | Sales Q/Q | 396.78% |
| Insider Own | 0.96% | Inst Own | 4.12% |
| Insider Trans | 0.00% | Inst Trans | -25.17% |
| Short Float | 0.44% | Earnings | Apr 16/b |
| Analyst Recom | 3.00 | Target Price | 2.00 |
| Avg Volume | 3.76M | 52W Range | 0.50 - 10.50 |
|
|
|
|
INVO BioScience, Inc. is a fertility company. It focuses on the creation of treatment options for patients diagnosed with infertility. It offers a patented medical device that is used for infertility treatment under the name INVOcell. The company was founded by Kathleen Karloff and Claude Ranoux on January 5, 2007 and is headquartered in Sarasota, FL. |
|
|
